Bordeaux, Boston, September 19, 2023 – 8:00 p.m. CEST: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME), medical technology company specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment, announces the postponement of the publication of its 2023 half-year results, initially scheduled for today, due to practical considerations.
The Company will publish its new financial calendar shortly.
If you wish to receive all of the company’s financial communications in real time, you can register directly by email to the following address: [email protected]